Participated · Seed · Apr 2026

Storii provides a platform that helps users record and preserve meaningful life stories by relying on automated phone calls and transcription technology. The service is positioned to help families document personal histories and lived experiences, with particular emphasis on older adults and legacy preservation. Since founding, Storii has raised $479,000 across three rounds combining seed investments and non-dilutive grants to fund product development and early market expansion. Investors in its early funding include a mix of venture firms and institutional backers such as Vision Plus Capital, Lightspeed Venture Partners, Source Code Capital, Goodwater Capital, General Catalyst, Bertelsmann Investments, DHVC, GGV Capital, and Notable Capital. The company says it is pursuing a measured growth strategy focused on product quality and user impact rather than rapid scaling. Its positioning sits at the intersection of consumer technology, aging services, and digital storytelling, aiming to deepen engagement through reminiscence-based experiences.

Participated · Series A · Jan 2026

Obita is building a global, enterprise-grade payments infrastructure platform designed to serve businesses that require seamless, compliant cross-border transactions. Founded by a team of seasoned fintech, payments and compliance professionals, the company aims to simplify and scale payment operations for enterprises worldwide. Obita plans to use newly raised capital to accelerate its business growth and deepen the technological capabilities of its payments network. Across its first two financing rounds, the startup has secured nearly US$30 million, underscoring early investor confidence. Key backers include Monolith, Vision Plus Capital, Mirana Ventures and Legend Capital. Although still in the Pre-A stage, the company is positioning itself as a foundational payments layer for global commerce and anticipates further expansion of both its product suite and geographic reach.

Participated · Series A · Nov 2025

Evotrex develops hybrid extended-range electric travel trailers designed to enable extended off-grid living. Its first model, the PG5, is an EREV with a battery pack recharged by an onboard gas engine, and the company revealed a functional version at CES after emerging from stealth. The PG5’s Premium trim is priced around $160,000, and Evotrex says 90% of its existing order book is for that fully loaded trim. The company plans to target roughly 1,000 units annually once production ramps and will manufacture in China with final assembly in California. Evotrex has prioritized service capability early—hiring its first service employee six months ago and bringing on its first sales hire more recently—as it spends the next 10–12 months on durability testing. The startup has raised $46 million to date and is using the new capital to complete testing, finalize manufacturing plans, and prepare for deliveries.

Participated · Series B · Oct 2025

Founded in late 2023, LiblibAI has become China’s largest multimodal AI model and creative community, integrating image, video, 3D and LoRA training capabilities into a single platform. Its product suite spans the entire AI creative workflow—from inspiration and visual design to dynamic video generation—enabling creators to move seamlessly from concept to finished content. The company’s “tools + community” strategy aggregates leading open- and closed-source generation models while incentivizing user contributions, helping it attract more than 20 million creators across illustration, photography, e-commerce, posters and IP design. In October 2025, LiblibAI released version 2.0, transforming the offering from a simple tool aggregator into a professional AI creative studio with multi-model composition and pro-level visual-effects templates. Management plans to leverage its newly raised capital to accelerate global expansion and build a worldwide multimodal content ecosystem. Financially, the firm has just secured a $130 million Series B round—the largest AI application raise in China this year—providing significant runway for growth and team expansion.

Participated · Series A · May 2025

Biostate AI develops generative AI models that predict the evolution of human disease and drug response using RNA sequencing data. The company combines software models with patented wetlab technologies, including its BIRT platform, to enable affordable, scalable collection of large transcriptomic and genomic datasets. It partners with hospitals, academic researchers, and biotech/pharma companies to source data and apply its models. Biostate AI operates sites in Houston, TX; Palo Alto, CA; Bangalore, India; and Shanghai, China. Founded by David Zhang and Ashwin Gopinath, the company plans to use new funding to expand operations and increase R&D efforts. Biostate AI builds a scalable biodata foundry centered on Total RNA sequencing using patent-pending Barcode-Integrated Reverse Transcription (BIRT) technology to analyze all RNA types, including lncRNAs, miRNAs, circRNAs, and eRNAs. The company also offers OmicsWeb Copilot, a conversational AI that leverages large-language models to help biologists analyze and visualize data, produce custom software and scripts, and access over 1,000 unique RNAseq datasets plus users' uploaded data. Biostate AI collaborates with academic, nonprofit, and industry partners on technology development and multiomic biodata collection. The startup plans to use its new funding to expand operations and accelerate development efforts. Led by CEO David Zhang and founded in 2023, Biostate AI maintains offices and laboratories in Palo Alto, CA and Houston, TX. The company positions itself to lower the costs of biological data collection for academic and industry collaborators.